ACHE and Alzheimer disease: Among the few drugs approved by the US Food and Drug Administration for the treatment of AD, Donepezil (DNPZ), a second-generation acetylcholinesterase inhibitor, is widely used for the treatment of mild, moderate and severe AD [1].